Rosen, P J <br/><br/>
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia research  Mar 2000 
 - 183-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/s0145-2126(99)00148-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cytarabine--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Recurrence<br/>Remission Induction<br/>Treatment Outcome